Glaxosmithkline (GSK)

Innovative early phase 1 and 2 studies are designed, set up and executed using the principles of experimental medicine. Scientists and clinicians are trained and interact to support the scientific knowledge and advance innovative and experimental clinical trial design in GSK. Our  position on the campus has enabled us to develop a large number of academic links and collaborations to support and conduct experimental and translational studies and to recruit patients by partnering with the local networks as well as in the wider environment.